BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Estep M, Armistead D, Hossain N, Elarainy H, Goodman Z, Baranova A, Chandhoke V, Younossi ZM. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2010;32:487-497. [PMID: 20497147 DOI: 10.1111/j.1365-2036.2010.04366.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 88] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Nie YQ, Cao J, Zhou YJ, Liang X, Du YL, Wan YJ, Li YY. The effect of miRNA-122 in regulating fat deposition in a cell line model. J Cell Biochem. 2014;115:839-846. [PMID: 24288170 DOI: 10.1002/jcb.24725] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
2 Wang M. miR‑433 protects pancreatic β cell growth in high‑glucose conditions. Mol Med Rep 2017;16:2604-10. [PMID: 28713945 DOI: 10.3892/mmr.2017.6925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nardelli C, Iaffaldano L, Pilone V, Labruna G, Ferrigno M, Carlomagno N, Dodaro CA, Forestieri P, Buono P, Salvatore F, Sacchetti L. Changes in the MicroRNA Profile Observed in the Subcutaneous Adipose Tissue of Obese Patients after Laparoscopic Adjustable Gastric Banding. J Obes 2017;2017:6754734. [PMID: 28386478 DOI: 10.1155/2017/6754734] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
4 Guan L, Hu X, Liu L, Xing Y, Zhou Z, Liang X, Yang Q, Jin S, Bao J, Gao H, Du M, Li J, Zhang L. bta-miR-23a involves in adipogenesis of progenitor cells derived from fetal bovine skeletal muscle. Sci Rep 2017;7:43716. [PMID: 28255176 DOI: 10.1038/srep43716] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 9.3] [Reference Citation Analysis]
5 Amacher DE. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease. Biomarkers 2014;19:541-52. [PMID: 25189636 DOI: 10.3109/1354750X.2014.958535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gerhard GS, DiStefano JK. Micro RNAs in the development of non-alcoholic fatty liver disease. World J Hepatol 2015; 7(2): 226-234 [PMID: 25729477 DOI: 10.4254/wjh.v7.i2.226] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
7 Thomas RA, Scicchitano MS, Mirabile RC, Chau NT, Frazier KS, Thomas HC. MicroRNA changes in rat mesentery and serum associated with drug-induced vascular injury. Toxicology and Applied Pharmacology 2012;262:310-20. [DOI: 10.1016/j.taap.2012.05.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
8 Kwon YJ, Cho YE, Cho AR, Choi WJ, Yun S, Park H, Kim HS, Cashion AK, Gill J, Lee H, Lee JW. The Possible Influence of Mediterranean Diet on Extracellular Vesicle miRNA Expression in Breast Cancer Survivors. Cancers (Basel) 2020;12:E1355. [PMID: 32466456 DOI: 10.3390/cancers12061355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Messner CJ, Schmidt S, Özkul D, Gaiser C, Terracciano L, Krähenbühl S, Suter-Dick L. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation. Int J Mol Sci 2021;22:9799. [PMID: 34575957 DOI: 10.3390/ijms22189799] [Reference Citation Analysis]
10 Naqvi AR, Fordham JB, Khan A, Nares S. MicroRNAs responsive to Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis LPS modulate expression of genes regulating innate immunity in human macrophages. Innate Immun 2014;20:540-51. [PMID: 24062196 DOI: 10.1177/1753425913501914] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
11 Ling H, Li X, Yao CH, Hu B, Liao D, Feng S, Wen G, Zhang L. The physiological and pathophysiological roles of adipocyte miRNAs. Biochem Cell Biol 2013;91:195-202. [DOI: 10.1139/bcb-2012-0053] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
12 Capobianco V, Nardelli C, Ferrigno M, Iaffaldano L, Pilone V, Forestieri P, Zambrano N, Sacchetti L. miRNA and protein expression profiles of visceral adipose tissue reveal miR-141/YWHAG and miR-520e/RAB11A as two potential miRNA/protein target pairs associated with severe obesity. J Proteome Res 2012;11:3358-69. [PMID: 22537031 DOI: 10.1021/pr300152z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
13 Zhang X, Asllanaj E, Amiri M, Portilla-Fernandez E, Bramer WM, Nano J, Voortman T, Pan Q, Ghanbari M. Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review. Eur J Clin Invest 2021;51:e13479. [PMID: 33350463 DOI: 10.1111/eci.13479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hendy OM, Rabie H, El Fouly A, Abdel-Samiee M, Abdelmotelb N, Elshormilisy AA, Allam M, Ali ST, Bahaa El-Deen NM, Abdelsattar S, Mohamed SM. The Circulating Micro-RNAs (-122, -34a and -99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases. Diabetes Metab Syndr Obes 2019;12:2715-23. [PMID: 31908512 DOI: 10.2147/DMSO.S231321] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
15 Oda S, Takeuchi M, Akai S, Shirai Y, Tsuneyama K, Yokoi T. miRNA in Rat Liver Sinusoidal Endothelial Cells and Hepatocytes and Application to Circulating Biomarkers that Discern Pathogenesis of Liver Injuries. The American Journal of Pathology 2018;188:916-28. [DOI: 10.1016/j.ajpath.2017.12.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
16 Szabo G, Csak T. Role of MicroRNAs in NAFLD/NASH. Dig Dis Sci. 2016;61:1314-1324. [PMID: 26769057 DOI: 10.1007/s10620-015-4002-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
17 Stephen S, Baranova A, Younossi ZM. Nonalcoholic fatty liver disease and bariatric surgery. Expert Review of Gastroenterology & Hepatology 2014;6:163-71. [DOI: 10.1586/egh.11.97] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
18 Kerr TA, Korenblat KM, Davidson NO. MicroRNAs and liver disease. Transl Res. 2011;157:241-252. [PMID: 21420035 DOI: 10.1016/j.trsl.2011.01.008] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 7.4] [Reference Citation Analysis]
19 Richardson K, Lai CQ, Parnell LD, Lee YC, Ordovas JM. A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. BMC Genomics 2011;12:504. [PMID: 21995669 DOI: 10.1186/1471-2164-12-504] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
20 Brandão BB, Guerra BA, Mori MA. Shortcuts to a functional adipose tissue: The role of small non-coding RNAs. Redox Biol 2017;12:82-102. [PMID: 28214707 DOI: 10.1016/j.redox.2017.01.020] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
21 聂娇, 李昌平. 非酒精性脂肪性肝病中microRNA调控细胞凋亡的机制. 世界华人消化杂志 2015; 23(15): 2389-2396 [DOI: 10.11569/wcjd.v23.i15.2389] [Reference Citation Analysis]
22 Chuang AY, Chuang JC, Zhai Z, Wu F, Kwon JH. NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells. Inflamm Bowel Dis. 2014;20:126-135. [PMID: 24297055 DOI: 10.1097/01.mib.0000436954.70596.9b] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 7.7] [Reference Citation Analysis]
23 Zhang J, Zhang L, Zhang T, Dong XM, Zhu Y, Chen LH. Reduced miR-433 expression is associated with advanced stages and early relapse of colorectal cancer and restored miR-433 expression suppresses the migration, invasion and proliferation of tumor cells in vitro and in nude mice. Oncol Lett 2018;15:7579-88. [PMID: 29740483 DOI: 10.3892/ol.2018.8275] [Reference Citation Analysis]
24 Meydan C, Shenhar-tsarfaty S, Soreq H. MicroRNA Regulators of Anxiety and Metabolic Disorders. Trends in Molecular Medicine 2016;22:798-812. [DOI: 10.1016/j.molmed.2016.07.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
25 Gottmann P, Ouni M, Saussenthaler S, Roos J, Stirm L, Jähnert M, Kamitz A, Hallahan N, Jonas W, Fritsche A. A computational biology approach of a genome-wide screen connected miRNAs to obesity and type 2 diabetes. Mol Metab. 2018;11:145-159. [PMID: 29605715 DOI: 10.1016/j.molmet.2018.03.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
26 Ma YS, Wu TM, Qian B, Liu YS, Ding H, Fan MM, Liu JB, Yu F, Wang HM, Shi Y, Gu LP, Li L, Tian LL, Wang PY, Wang GR, Wu ZJ, Zou QF, Ling CC, Fu D. KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation. J Cell Mol Med 2021;25:4040-52. [PMID: 33621431 DOI: 10.1111/jcmm.16371] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Gao S, Liu L, Zhu S, Wang D, Wu Q, Ning G, Feng S. MicroRNA-197 regulates chondrocyte proliferation, migration, and inflammation in pathogenesis of osteoarthritis by targeting EIF4G2. Biosci Rep 2020;40:BSR20192095. [PMID: 32880393 DOI: 10.1042/BSR20192095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Zong Y, Yan J, Jin L, Xu B, He Z, Zhang R, Hu C, Jia W. Relationship between circulating miR-132 and non-alcoholic fatty liver disease in a Chinese population. Hereditas 2020;157:22. [PMID: 32443971 DOI: 10.1186/s41065-020-00136-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Płatek T, Polus A, Góralska J, Raźny U, Dziewońska A, Micek A, Dembińska-Kieć A, Solnica B, Malczewska-Malec M. Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects. Genes (Basel) 2021;12:307. [PMID: 33670024 DOI: 10.3390/genes12020307] [Reference Citation Analysis]
30 Cazanave SC, Mott JL, Elmi NA, Bronk SF, Masuoka HC, Charlton MR, Gores GJ. A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA. J Lipid Res. 2011;52:1517-1525. [PMID: 21633093 DOI: 10.1194/jlr.m014654] [Cited by in Crossref: 58] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
31 Gori M, Arciello M, Balsano C. MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma. Biomed Res Int. 2014;2014:741465. [PMID: 24745023 DOI: 10.1155/2014/741465] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
32 Mysore R, Zhou Y, Sädevirta S, Savolainen-Peltonen H, Nidhina Haridas PA, Soronen J, Leivonen M, Sarin AP, Fischer-Posovszky P, Wabitsch M, Yki-Järvinen H, Olkkonen VM. MicroRNA-192* impairs adipocyte triglyceride storage. Biochim Biophys Acta 2016;1861:342-51. [PMID: 26747651 DOI: 10.1016/j.bbalip.2015.12.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
33 Fiorino S, Bacchi-Reggiani ML, Visani M, Acquaviva G, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Di Tommaso L, Bondi A, Sabbatani S, Domanico A, Fabbri C, Leandri P, Pession A, Jovine E, de Biase D. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World J Gastroenterol 2016; 22(15): 3907-3936 [PMID: 27099435 DOI: 10.3748/wjg.v22.i15.3907] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
34 Hamar P. Role of regulatory micro RNAs in type 2 diabetes mellitus-related inflammation. Nucleic Acid Ther 2012;22:289-94. [PMID: 22950794 DOI: 10.1089/nat.2012.0381] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
35 Arner P, Kulyté A. MicroRNA regulatory networks in human adipose tissue and obesity. Nat Rev Endocrinol 2015;11:276-88. [PMID: 25732520 DOI: 10.1038/nrendo.2015.25] [Cited by in Crossref: 255] [Cited by in F6Publishing: 244] [Article Influence: 42.5] [Reference Citation Analysis]
36 Celikbilek M, Baskol M, Taheri S, Deniz K, Dogan S, Zararsiz G, Gursoy S, Guven K, Ozbakır O, Dundar M, Yucesoy M. Circulating microRNAs in patients with non-alcoholic fatty liver disease. World J Hepatol 2014; 6(8): 613-620 [PMID: 25232454 DOI: 10.4254/wjh.v6.i8.613] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
37 Tang PM, Lan H. MicroRNAs in TGF-β/Smad-mediated Tissue Fibrosis. Curr Pathobiol Rep 2014;2:235-43. [DOI: 10.1007/s40139-014-0060-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
38 Li D, Liu Y, Gao W, Han J, Yuan R, Zhang M, Pang W. Inhibition of miR-324-5p increases PM20D1-mediated white and brown adipose loss and reduces body weight in juvenile mice. Eur J Pharmacol 2019;863:172708. [PMID: 31568785 DOI: 10.1016/j.ejphar.2019.172708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
39 Bratkovič T, Glavan G, Strukelj B, Zivin M, Rogelj B. Exploiting microRNAs for cell engineering and therapy. Biotechnol Adv 2012;30:753-65. [PMID: 22286072 DOI: 10.1016/j.biotechadv.2012.01.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
40 Yang Z, Cappello T, Wang L. Emerging role of microRNAs in lipid metabolism. Acta Pharm Sin B 2015;5:145-50. [PMID: 26579440 DOI: 10.1016/j.apsb.2015.01.002] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 15.0] [Reference Citation Analysis]
41 Csak T, Bala S, Lippai D, Satishchandran A, Catalano D, Kodys K, Szabo G. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int. 2015;35:532-541. [PMID: 25040043 DOI: 10.1111/liv.12633] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 11.4] [Reference Citation Analysis]
42 Yang Z, Tsuchiya H, Zhang Y, Hartnett ME, Wang L. MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein. J Biol Chem 2013;288:28893-9. [PMID: 23979134 DOI: 10.1074/jbc.M113.502682] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
43 Saxena A, Sachin K. A Network Biology Approach for Assessing the Role of Pathologic Adipose Tissues in Insulin Resistance Using Meta-analysis of Microarray Datasets. Curr Genomics 2018;19:630-66. [PMID: 30386174 DOI: 10.2174/1389202919666180726125645] [Reference Citation Analysis]
44 Liu XL, Cao HX, Fan JG. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease. J Dig Dis. 2016;17:708-715. [PMID: 27628945 DOI: 10.1111/1751-2980.12408] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
45 Vailati-Riboni M, Farina G, Batistel F, Heiser A, Mitchell MD, Crookenden MA, Walker CG, Kay JK, Meier S, Roche JR, Loor JJ. Far-off and close-up dry matter intake modulate indicators of immunometabolic adaptations to lactation in subcutaneous adipose tissue of pasture-based transition dairy cows. J Dairy Sci 2017;100:2334-50. [PMID: 28088407 DOI: 10.3168/jds.2016-11790] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
46 Casado-Díaz A, Anter J, Müller S, Winter P, Quesada-Gómez JM, Dorado G. Transcriptomic Analyses of Adipocyte Differentiation From Human Mesenchymal Stromal-Cells (MSC). J Cell Physiol 2017;232:771-84. [PMID: 27349923 DOI: 10.1002/jcp.25472] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
47 Mikaelian I, Cameron M, Dalmas DA, Enerson BE, Gonzalez RJ, Guionaud S, Hoffmann PK, King NMP, Lawton MP, Scicchitano MS, Smith HW, Thomas RA, Weaver JL, Zabka TS; The Vascular Injury Working Group of the Predictive Safety Consortium. Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future. Toxicol Pathol 2014;42:635-57. [DOI: 10.1177/0192623314525686] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
48 Sun C, Fan JG, Qiao L. Potential epigenetic mechanism in non-alcoholic Fatty liver disease. Int J Mol Sci. 2015;16:5161-5179. [PMID: 25751727 DOI: 10.3390/ijms16035161] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
49 Géczi D, Nagy B, Szilágyi M, Penyige A, Klekner Á, Jenei A, Virga J, Birkó Z. Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients. Int J Mol Sci 2021;22:5058. [PMID: 34064637 DOI: 10.3390/ijms22105058] [Reference Citation Analysis]
50 Sun S, Wang X, Xu X, Di H, Du J, Xu B, Wang Q, Wang J. MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma. Oncotarget 2017;8:5057-68. [PMID: 27926502 DOI: 10.18632/oncotarget.13789] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
51 Campisano S, La Colla A, Echarte SM, Chisari AN. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. Nutr Res Rev 2019;32:128-45. [PMID: 30707092 DOI: 10.1017/S0954422418000239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
52 Angelino E, Reano S, Ferrara M, Agosti E, Graziani A, Filigheddu N. Antifibrotic activity of acylated and unacylated ghrelin. Int J Endocrinol 2015;2015:385682. [PMID: 25960743 DOI: 10.1155/2015/385682] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
53 Jin BX, Zhang YH, Jin WJ, Sun XY, Qiao GF, Wei YY, Sun LB, Zhang WH, Li N. MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis. Sci Rep. 2015;5:15026. [PMID: 26456479 DOI: 10.1038/srep15026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
54 Mavridis K, Gueugnon F, Petit-Courty A, Courty Y, Barascu A, Guyetant S, Scorilas A. The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients. Br J Cancer 2015;112:1527-35. [PMID: 25867273 DOI: 10.1038/bjc.2015.119] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
55 Dongiovanni P, Meroni M, Longo M, Fargion S, Fracanzani AL. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. Int J Mol Sci 2018;19:E3966. [PMID: 30544653 DOI: 10.3390/ijms19123966] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 15.3] [Reference Citation Analysis]
56 Mehta R, Otgonsuren M, Younoszai Z, Allawi H, Raybuck B, Younossi Z. Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease. BMJ Open Gastroenterol 2016;3:e000096. [PMID: 27493762 DOI: 10.1136/bmjgast-2016-000096] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
57 Lakner AM, Bonkovsky HL, Schrum LW. microRNAs: Fad or future of liver disease. World J Gastroenterol 2011; 17(20): 2536-2542 [PMID: 21633658 DOI: 10.3748/wjg.v17.i20.2536] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
58 Leti F, Malenica I, Doshi M, Courtright A, Van Keuren-Jensen K, Legendre C, Still CD, Gerhard GS, DiStefano JK. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis. Transl Res. 2015;166:304-314. [PMID: 26001595 DOI: 10.1016/j.trsl.2015.04.014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
59 Chen L, Li C, Peng Z, Zhao J, Gong G, Tan D. miR-197 Expression in Peripheral Blood Mononuclear Cells from Hepatitis B Virus-Infected Patients. Gut Liver 2013;7:335-42. [PMID: 23710316 DOI: 10.5009/gnl.2013.7.3.335] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
60 Gholami M, Larijani B, Zahedi Z, Mahmoudian F, Bahrami S, Omran SP, Saadatian Z, Hasani-Ranjbar S, Taslimi R, Bastami M, Amoli MM. Inflammation related miRNAs as an important player between obesity and cancers. J Diabetes Metab Disord 2019;18:675-92. [PMID: 31890692 DOI: 10.1007/s40200-019-00459-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Maurantonio M, Ballestri S, Odoardi MR, Lonardo A, Loria P. Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk? Arch Med Res. 2011;42:337-353. [PMID: 21843565 DOI: 10.1016/j.arcmed.2011.08.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
62 Gerhard GS, Malenica I, Llaci L, Chu X, Petrick AT, Still CD, DiStefano JK. Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways. Clin Epigenetics. 2018;10:93. [PMID: 30005700 DOI: 10.1186/s13148-018-0525-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
63 Sharma H, Estep M, Birerdinc A, Afendy A, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2013;28:1410-1415. [PMID: 23663110 DOI: 10.1111/jgh.12268] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
64 Zhao J, Lawless MW. Stop feeding cancer: pro-inflammatory role of visceral adiposity in liver cancer. Cytokine. 2013;64:626-637. [PMID: 24120848 DOI: 10.1016/j.cyto.2013.09.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
65 Estep JM, Goodman Z, Sharma H, Younossi E, Elarainy H, Baranova A, Younossi Z. Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD. Liver Int. 2015;35:1367-1372. [PMID: 24684403 DOI: 10.1111/liv.12555] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
66 Roderburg C, Mollnow T, Bongaerts B, Elfimova N, Vargas Cardenas D, Berger K, Zimmermann H, Koch A, Vucur M, Luedde M, Hellerbrand C, Odenthal M, Trautwein C, Tacke F, Luedde T. Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS One. 2012;7:e32999. [PMID: 22412969 DOI: 10.1371/journal.pone.0032999] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 7.7] [Reference Citation Analysis]
67 Zhang C, Bai N, Huang W, Zhang P, Luo Y, Men S, Wen T, Tong H, Wang S, Tian Y. The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays. Ann Hematol 2016;95:1833-43. [DOI: 10.1007/s00277-016-2781-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
68 Liu Z, Wang Y, Borlak J, Tong W. Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades. Sci Rep 2016;6:23709. [PMID: 27045805 DOI: 10.1038/srep23709] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
69 Littlejohn GO. Fibrositis/fibromyalgia syndrome in the workplace. Rheum Dis Clin North Am. 1989;15:45-60. [PMID: 2644678 DOI: 10.1074/jbc.m115.683813] [Cited by in Crossref: 86] [Cited by in F6Publishing: 55] [Article Influence: 2.7] [Reference Citation Analysis]
70 Milagro FI, Miranda J, Portillo MP, Fernandez-Quintela A, Campión J, Martínez JA. High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers. PLoS One 2013;8:e54319. [PMID: 23335998 DOI: 10.1371/journal.pone.0054319] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
71 Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Scholten D, Frey N, Koch A, Trautwein C, Tacke F, Luedde T. Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One 2013;8:e54612. [PMID: 23372743 DOI: 10.1371/journal.pone.0054612] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 13.4] [Reference Citation Analysis]
72 Chinen I, Nakahama T, Kimura A, Nguyen NT, Takemori H, Kumagai A, Kayama H, Takeda K, Lee S, Hanieh H, Ripley B, Millrine D, Dubey PK, Nyati KK, Fujii-Kuriyama Y, Chowdhury K, Kishimoto T. The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis. Int Immunol 2015;27:405-15. [PMID: 25862525 DOI: 10.1093/intimm/dxv015] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
73 Son YH, Ka S, Kim AY, Kim JB. Regulation of Adipocyte Differentiation via MicroRNAs. Endocrinol Metab (Seoul) 2014;29:122-35. [PMID: 25031884 DOI: 10.3803/EnM.2014.29.2.122] [Cited by in Crossref: 54] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
74 Müller G. Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab Syndr Obes 2012;5:247-82. [PMID: 22924003 DOI: 10.2147/DMSO.S32923] [Cited by in Crossref: 97] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
75 Broermann A, Schmid R, Gabrielyan O, Sakowski M, Eisele C, Keller S, Wolff M, Baum P, Stierstorfer B, Huber J, Krämer BK, Hocher B, Streicher R, Delić D. Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats. Int J Mol Sci 2020;22:E382. [PMID: 33396535 DOI: 10.3390/ijms22010382] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
76 Csak T, Bala S, Lippai D, Kodys K, Catalano D, Iracheta-Vellve A, Szabo G. MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis. PLoS One. 2015;10:e0129251. [PMID: 26042593 DOI: 10.1371/journal.pone.0129251] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 8.7] [Reference Citation Analysis]
77 Yu Y, Zhu J, Liu J, Huang M, Wan JX. Identification of 8-miRNAs as biomarkers for nonalcoholic fatty liver disease. J Cell Physiol 2019;234:17361-9. [PMID: 30790285 DOI: 10.1002/jcp.28356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Gasparotto AS, Borges DO, Sassi MGM, Milani A, Rech DL, Terres M, Ely PB, Ramos MJ, Meihnardt NG, Mattevi VS. Differential expression of miRNAs related to angiogenesis and adipogenesis in subcutaneous fat of obese and nonobese women. Mol Biol Rep 2019;46:965-73. [DOI: 10.1007/s11033-018-4553-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
79 Pek SL, Sum CF, Lin MX, Cheng AK, Wong MT, Lim SC, Tavintharan S. Circulating and visceral adipose miR-100 is down-regulated in patients with obesity and Type 2 diabetes. Mol Cell Endocrinol. 2016;427:112-123. [PMID: 26973292 DOI: 10.1016/j.mce.2016.03.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
80 Manoel Alves J, Handerson Gomes Teles R, do Valle Gomes Gatto C, Muñoz VR, Regina Cominetti M, Garcia de Oliveira Duarte AC. Mapping Research in the Obesity, Adipose Tissue, and MicroRNA Field: A Bibliometric Analysis. Cells 2019;8:E1581. [PMID: 31817583 DOI: 10.3390/cells8121581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Lee J, Kim Y, Friso S, Choi SW. Epigenetics in non-alcoholic fatty liver disease. Mol Aspects Med. 2016; Nov 23. [Epub ahead of print]. [PMID: 27889327 DOI: 10.1016/j.mam.2016.11.008] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 11.6] [Reference Citation Analysis]
82 Shen J, Chan HL, Wong GL, Chan AW, Choi PC, Chan HY, Chim AM, Yeung DK, Yu J, Chu WC. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers. Aliment Pharmacol Ther. 2012;36:1057-1066. [PMID: 23066946 DOI: 10.1111/apt.12091] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
83 Estep M, Abawi M, Jarrar M, Wang L, Stepanova M, Elariny H, Moazez A, Goodman Z, Chandhoke V, Baranova A. Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. Obes Surg. 2011;21:1750-1757. [PMID: 21744131 DOI: 10.1007/s11695-011-0475-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
84 Wiczling P, Daghir-Wojtkowiak E, Kaliszan R, Markuszewski MJ, Limon J, Koczkowska M, Stukan M, Kuźniacka A, Ratajska M. Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects. PLoS One 2019;14:e0221764. [PMID: 31465488 DOI: 10.1371/journal.pone.0221764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
85 Chen S, Chen D, Yang H, Wang X, Wang J, Xu C. Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis. BMC Gastroenterol. 2020;20:39. [PMID: 32070295 DOI: 10.1186/s12876-020-01189-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
86 Badawy HK, Abo-Elmatty DM, Mesbah NM. Differential expression of MicroRNA let-7e and 296-5p in plasma of Egyptian patients with essential hypertension. Heliyon 2018;4:e00969. [PMID: 30519661 DOI: 10.1016/j.heliyon.2018.e00969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
87 Guo Y, Xiong Y, Sheng Q, Zhao S, Wattacheril J, Flynn CR. A micro-RNA expression signature for human NAFLD progression. J Gastroenterol. 2016;51:1022-1030. [PMID: 26874844 DOI: 10.1007/s00535-016-1178-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 9.4] [Reference Citation Analysis]
88 Cinti S. Adipose Organ Development and Remodeling. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1357-431. [DOI: 10.1002/cphy.c170042] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 14.3] [Reference Citation Analysis]